Piramal Pharma earnings call announcements

Every Piramal Pharma earnings call announcement on NSE and BSE, newest first, each with its own page.

Time

2 announcements

27 Oct 2026 21:07 IST NSE

Q2FY27 revenue ₹2,617 Cr (+28% YoY), EBITDA margin 14.7% (+372 bps), PAT ₹5 Cr vs loss of ₹99 Cr. FY27 revenue growth outlook raised to 19-20%.

29 Jul 2026 20:54 IST NSE

Piramal Pharma started FY27 with 17% revenue growth and 72% EBITDA expansion. Momentum was driven by CDMO recovery and power brands.